This Fool considers how two low-risk and well-established FTSE shares could offer stability and growth during a period of market volatility.

U.K. stocks are slightly down Monday morning, due largely to weakness in the mining sector after data showed a contraction in the ...

Two FTSE 100 stocks in Harvey Jones' portfolio have suffered double-digit losses. He's standing by them for now, but he's ...

Consumer health goods group Haleon has appointed Jo Cooper as the new General Manager for its operations in the UK and Ireland.

She was previously the supplier's head of commercial excellence for Europe, Middle East, Africa & Latin America ...

“We know that slowdowns in luxury tend to be quite short-lived. And we also know that the leading brands have centuries of adapting to changes in consumer preferences,” Middleton says. She notes that ...

Cura Health, a leading provider in Kuwait's pharmaceutical and healthcare sector, today hosted a wellness event for its ...

JP Morgan Cazenove and Morgan Stanley were global coordinators on the sale of a 7.7% stake in the UK consumer healthcare ...

Pfizer Inc. (NYSE:PFE) has announced the sale of shares worth £2.50 billion ($3.05 billion) in British consumer healthcare ...

In this note, while we briefly touch upon Pfizer’s performance in 2024, we focus on the impact on PFE stock and how 2025 ...

Pfizer will lower its stake in Haleon from 15 percent to about 7.3% by selling shares worth 2.50 billion pounds ($3.05 ...

Pfizer divests $3.05 billion of Haleon shares, cutting its stake to 7.3% in a strategic shift to refocus on core ...